These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 20183446)

  • 21. A parametric model for detecting hormetic effects in developmental toxicity studies.
    Hunt DL; Bowman D
    Risk Anal; 2004 Feb; 24(1):65-72. PubMed ID: 15028001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose-escalation designs in oncology: ADEPT and the CRM.
    Shu J; O'Quigley J
    Stat Med; 2008 Nov; 27(26):5345-53; discussion 5354-5. PubMed ID: 18752259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of variance function estimation on nonlinear calibration inference in immunoassay data.
    Belanger BA; Davidian M; Giltinan DM
    Biometrics; 1996 Mar; 52(1):158-75. PubMed ID: 8934590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Some general estimation methods for nonlinear mixed-effects models.
    Davidian M; Giltinan DM
    J Biopharm Stat; 1993 Mar; 3(1):23-55. PubMed ID: 8485535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outlier robust nonlinear mixed model estimation.
    Williams JD; Birch JB; Abdel-Salam AS
    Stat Med; 2015 Apr; 34(8):1304-16. PubMed ID: 25581342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship between baseline value and its change: problems in categorization and the proposal of a new method.
    Tu YK; Baelum V; Gilthorpe MS
    Eur J Oral Sci; 2005 Aug; 113(4):279-88. PubMed ID: 16048519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Bayesian approach to a logistic regression model with incomplete information.
    Choi T; Schervish MJ; Schmitt KA; Small MJ
    Biometrics; 2008 Jun; 64(2):424-30. PubMed ID: 17764482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Global tests for analysis of multiple tumour data from animal carcinogenicity experiments.
    Chen JJ
    Stat Med; 1996 Jun; 15(11):1217-25. PubMed ID: 8804149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Designs for testing lack of fit for a nonlinear dose-response curve model.
    Lupinacci PJ; Raghavarao D
    J Biopharm Stat; 2000 Feb; 10(1):45-53. PubMed ID: 10709800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An adaptive dose-finding design incorporating both toxicity and efficacy.
    Zhang W; Sargent DJ; Mandrekar S
    Stat Med; 2006 Jul; 25(14):2365-83. PubMed ID: 16220478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exact analysis of dose response for multiple correlated binary outcomes.
    Han KE; Catalano PJ; Senchaudhuri P; Mehta C
    Biometrics; 2004 Mar; 60(1):216-24. PubMed ID: 15032792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Constrained four parameter logistic model.
    Altan S; Manola A; Davidian M; Raghavarao D
    Dev Biol (Basel); 2002; 107():71-6. PubMed ID: 12079194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Issues in the design and interpretation of chronic toxicity and carcinogenicity studies in rodents: approaches to dose selection.
    Rhomberg LR; Baetcke K; Blancato J; Bus J; Cohen S; Conolly R; Dixit R; Doe J; Ekelman K; Fenner-Crisp P; Harvey P; Hattis D; Jacobs A; Jacobson-Kram D; Lewandowski T; Liteplo R; Pelkonen O; Rice J; Somers D; Turturro A; West W; Olin S
    Crit Rev Toxicol; 2007; 37(9):729-837. PubMed ID: 17957539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A high-dimensional joint model for longitudinal outcomes of different nature.
    Faes C; Aerts M; Molenberghs G; Geys H; Teuns G; Bijnens L
    Stat Med; 2008 Sep; 27(22):4408-27. PubMed ID: 18551509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Testing effect of a drug using multiple nested models for the dose-response.
    Baayen C; Hougaard P; Pipper CB
    Biometrics; 2015 Jun; 71(2):417-27. PubMed ID: 25660353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The benchmark dose method--review of available models, and recommendations for application in health risk assessment.
    Filipsson AF; Sand S; Nilsson J; Victorin K
    Crit Rev Toxicol; 2003; 33(5):505-42. PubMed ID: 14594105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A confidence-limit-based approach to the assessment of Hardy-Weinberg equilibrium.
    Wellek S; Goddard KA; Ziegler A
    Biom J; 2010 Apr; 52(2):253-70. PubMed ID: 20394081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New approaches to drug discovery and development: a mechanism-based approach to pharmaceutical research and its application to BNP7787, a novel chemoprotective agent.
    Hausheer FH; Kochat H; Parker AR; Ding D; Yao S; Hamilton SE; Petluru PN; Leverett BD; Bain SH; Saxe JD
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S3-15. PubMed ID: 12819940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On the assessment of dose proportionality: a comparison of two slope approaches.
    Cheng B; Chow SC; Su WL
    J Biopharm Stat; 2006 May; 16(3):385-92. PubMed ID: 16724492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bayesian hypothesis testing-use in interpretation of measurements.
    Miller G; Martz H; Little T; Bertelli L
    Health Phys; 2008 Mar; 94(3):248-54. PubMed ID: 18301098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.